-TheWire Science * The Indian government has consistently discouraged compulsory licenses on generic drugs.   * One of the big questions the India government has not answered is why it isn’t using pharma PSUs to produce drugs and vaccines. * Not one member of Indian industry is willing to stand up and fight for compulsory licenses, and for patients, says lawyer Murali Neelakantan. India has played a crucial role in supporting South Africa, as a...

-The Hindu There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. This can happen through patent owners voluntarily licensing their products to other companies, especially Indian producers who are experienced at...

-The Hindu Business Line WTO has allowed countries to issue compulsory licenses during emergencies A Division Bench of the Kerala High Court on Tuesday asked the Centre to respond to a plea for invoking the compulsory licensing to allow other capable vaccine manufacturers to produce Covid vaccines. The Bench comprising Justice Raja Vijayaraghavan and Justice M.R.Anitha passed the directive when a public interest litigation in this regard came up for hearing. The petition...

-The Hindu The U.S.-supported move will have an effect if countries simultaneously address non-IP bottlenecks among other things The United States has finally relented and declared its support for a temporary waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement for COVID-19 vaccines at the World Trade Organisation (WTO). In October 2020, India and South Africa, at the WTO, proposed waiving Sections 1, 4, 5, and 7 of Part II...

-The Indian Express A waiver on IP protections would mean pharmaceutical firms and vaccine makers across the world can learn how to make these vaccines without fear of lawsuits from companies that originally developed them. In a move that could potentially help increase production of Covid-19 vaccines around the world, the United States on Wednesday announced its support for waiving intellectual property (IP) protections for these vaccines. Subsequently, the European Union (EU) agreed...